190 related articles for article (PubMed ID: 14576484)
1. Metachronous development of nonamyloidogenic [lambda] light chain deposition disease and IgG heavy chain amyloidosis in the same patient.
Copeland JN; Kouides PA; Grieff M; Nadasdy T
Am J Surg Pathol; 2003 Nov; 27(11):1477-82. PubMed ID: 14576484
[TBL] [Abstract][Full Text] [Related]
2. Pseudo-gamma heavy chain (IgG4 lambda) deposition disease.
Tubbs RR; Berkley V; Valenzuela R; McMahon JT; Gephardt GN; Fishleder AJ; Nally JV; Pohl MA; Bukowski RM; Lichtin AE
Mod Pathol; 1992 Mar; 5(2):185-90. PubMed ID: 1574496
[TBL] [Abstract][Full Text] [Related]
3. Disappearance of immunoglobulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis.
Safadi S; Saad A; Quint PS; Sethi S; Leung N; Kurtin P; Nasr SH
Nephrol Dial Transplant; 2015 Jul; 30(7):1151-5. PubMed ID: 25796445
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis.
Buxbaum JN; Chuba JV; Hellman GC; Solomon A; Gallo GR
Ann Intern Med; 1990 Mar; 112(6):455-64. PubMed ID: 2106817
[TBL] [Abstract][Full Text] [Related]
5. Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management.
Bridoux F; Javaugue V; Bender S; Leroy F; Aucouturier P; Debiais-Delpech C; Goujon JM; Quellard N; Bonaud A; Clavel M; Trouillas P; Di Meo F; Gombert JM; Fermand JP; Jaccard A; Cogné M; Touchard G; Sirac C
Kidney Int; 2017 Feb; 91(2):423-434. PubMed ID: 27773425
[TBL] [Abstract][Full Text] [Related]
6. A case of monoclonal immunoglobulin light- and heavy-chain deposition disease exhibiting atypical deposition with fibrillary structures, successfully treated with chemotherapy.
Nakatsuka A; Maeshima Y; Sarai A; Yanai H; Sugiyama H; Yamasaki Y; Makino H
Clin Nephrol; 2005 Sep; 64(3):221-7. PubMed ID: 16175947
[TBL] [Abstract][Full Text] [Related]
7. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
[TBL] [Abstract][Full Text] [Related]
8. AH amyloidosis associated with an immunoglobulin heavy chain variable region (VH1) fragment: a case report.
Miyazaki D; Yazaki M; Gono T; Kametani F; Tsuchiya A; Matsuda M; Takenaka Y; Hosh Y; Ikeda S
Amyloid; 2008 Jun; 15(2):125-8. PubMed ID: 18484339
[TBL] [Abstract][Full Text] [Related]
9. Co-deposition of amyloidogenic immunoglobulin light and heavy chains in localized pulmonary amyloidosis.
Kaplan B; Martin BM; Boykov O; Gal R; Pras M; Shechtman I; Saute M; Kramer MR
Virchows Arch; 2005 Oct; 447(4):756-61. PubMed ID: 16021505
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of nephrotic syndrome induced by lambda light chain deposition disease using lenalidomide: A case report and review of the literature
.
Mima A; Nagahara D; Tansho K
Clin Nephrol; 2018 Jun; 89(6):461-468. PubMed ID: 29393843
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin heavy chain can be amyloidogenic: morphologic characterization including immunoelectron microscopy.
Mai HL; Sheikh-Hamad D; Herrera GA; Gu X; Truong LD
Am J Surg Pathol; 2003 Apr; 27(4):541-5. PubMed ID: 12657941
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive molecular characterization of a heavy chain deposition disease case.
Bender S; Ayala MV; Javaugue V; Bonaud A; Cogné M; Touchard G; Jaccard A; Bridoux F; Sirac C
Haematologica; 2018 Nov; 103(11):e557-e560. PubMed ID: 30026336
[No Abstract] [Full Text] [Related]
13. Adult Fanconi syndrome in primary amyloidosis with lambda light-chain proteinuria.
Rikitake O; Sakemi T; Yoshikawa Y; Nagano Y; Watanabe T
Jpn J Med; 1989; 28(4):523-6. PubMed ID: 2509772
[TBL] [Abstract][Full Text] [Related]
14. IgG heavy-chain deposition disease.
Katz A; Zent R; Bargman JM
Mod Pathol; 1994 Oct; 7(8):874-8. PubMed ID: 7838842
[TBL] [Abstract][Full Text] [Related]
15. Heavy chain deposition disease: the disease spectrum.
Kambham N; Markowitz GS; Appel GB; Kleiner MJ; Aucouturier P; D'agati VD
Am J Kidney Dis; 1999 May; 33(5):954-62. PubMed ID: 10213655
[TBL] [Abstract][Full Text] [Related]
16. Collapsing Glomerulopathy in Lambda Light Chain Amyloidosis: A Report of 2 Cases.
Khalighi MA; Gallan AJ; Chang A; Meehan SM
Am J Kidney Dis; 2018 Oct; 72(4):612-616. PubMed ID: 29908693
[TBL] [Abstract][Full Text] [Related]
17. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
[TBL] [Abstract][Full Text] [Related]
18. Nephrotic syndrome, renal insufficiency, and a monoclonal gammopathy.
Markowitz GS; Zdunek MP; D'Agati VD
Am J Kidney Dis; 2001 Nov; 38(5):1135-40. PubMed ID: 11684573
[No Abstract] [Full Text] [Related]
19. Nephrotic syndrome and lambda light-chain monoclonal gammopathy suggestive of primary amyloidosis with positive staining for AA amyloid.
Riveiro-Barciela M; Martínez-Valle F; Vilardell-Tarrés M
J Am Geriatr Soc; 2012 Oct; 60(10):1974-5. PubMed ID: 23057449
[No Abstract] [Full Text] [Related]
20. Cardiac involvement in heavy and light chain amyloidosis: A case report and literature review.
Otaka Y; Nakazato Y; Tsutsui T; Tamura J
Medicine (Baltimore); 2019 Nov; 98(46):e17999. PubMed ID: 31725668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
